Integra LifeSciences Holdings Corporation (IART) |
| 12.0875 0.178 (1.49%) 10-26 09:50 |
| Open: | 12.05 |
| High: | 12.21 |
| Low: | 12 |
| Volume: | 26,067 |
| Market Cap: | 940(M) |
| PE Ratio: | 5.12 |
| Exchange: | NASDAQ Global Select |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 16.77 |
| Resistance 1: | 14.78 |
| Pivot price: | 13.14 |
| Support 1: | 11.57 |
| Support 2: | 9.63 |
| 52w High: | 20.49 |
| 52w Low: | 8.7 |
Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.
| EPS | 0.170 |
| Book Value | 13.710 |
| PEG Ratio | 0.67 |
| Gross Profit | 12.028 |
| Profit Margin (%) | 0.79 |
| Operating Margin (%) | 6.33 |
| Return on Assets (ttm) | 3.1 |
| Return on Equity (ttm) | 1.2 |
Sun, 25 Oct 2026
Integra LifeSciences Holdings Corporation (IART) Stock Price, News, Quote & History - Yahoo! Finance Canada
Sat, 24 Oct 2026
Integra LifeSciences (IART) Stock Sees Fair Value Cut After Analyst Target Reductions - Yahoo Finance
Sat, 24 Oct 2026
Integra LifeSciences Holdings Corporation Estimates – NASDAQ:IART - TradingView
Fri, 23 Oct 2026
Integra LifeSciences: Progress Remains Frustratingly Slow, But Valuation Is Getting Interesting - Seeking Alpha
Fri, 23 Oct 2026
Truist Adjusts Price Target on Integra LifeSciences to $13 From $15, Maintains Hold Rating - Yahoo Finance
Thu, 22 Oct 2026
Integra LifeSciences' $2.1B Refinancing Merits A Closer Look - Benzinga
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |